The Compounding Effect of Patient Satisfaction
Alan Nalle describes how to maximize a patient’s lifetime value through a better payment experience.
A Short Guide to Avoiding Unwelcome Surprises
Surprise medical bills are a top concern of American consumers today. HFMA President and CEO Joe Fifer introduces a guide to help consumers avoid these unexpected out-of-network bills.
Why Your Access Strategy Demands Pricing Transparency
Consumers have come to expect price transparency in health care, which has greatly increased the strategic and operational importance of providers’ charge master descriptions and other pricing frameworks.
Reconciling Charges and Pricing Through Charge Description Master Redesign
Providers should restructure pricing schedules to bring charges into better alignment with the actual cost of services, developing a long-term pricing model that is attractive to both patients and employers.
Understanding the 7 Options for CMS’s Hospital Charge Posting Rule
Hospitals can choose to post charges in a variety of ways, but not all methods comply with CMS’s recent rule that takes effect on Jan. 1, 2019.
Ask the Experts: Charity Care and Free Services
Is a free service provided on the basis of presumptive eligibility allowable for charity on the S-10 worksheet?
Calculating KPIs for Value-Based Payment Models
If hospitals and health systems know the patients for whom they’re at risk and the benchmarks against which they are held accountable, they can lower costs and improve outcomes for an entire population—not just a single patient.
Ask the Experts: Late Charge Reports
What is the general consensus on lab charges that are consistently late because of the need for specimen growth?
Success Factors for Getting High-Cost Drugs Approved
The University of Rochester Medical Center’s high-cost drug manager works to help patients get access to appropriate drugs and mitigates the financial risk associated with buying and administering them.
Outsourced Revenue Cycle Operations Experience Higher Denial Rates
Outsourced revenue cycle operations have lower performance on denial rates but other factors may still make outsourcing a viable option.